Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis Neslihan Nisa GeciciMuhammet Enes GursesAshish H. Shah Review Open access 15 April 2024 Pages: 1 - 11
Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis Seyed Farzad MaroufiManijeh AssarHamid Borghei-Razavi Review 08 April 2024 Pages: 13 - 25
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes Gang LiQilong TianQing Cai Research 30 April 2024 Pages: 27 - 33
Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status Johanna JostKlaus Völkerfor the MMH Trial Investigators Research Open access 01 April 2024 Pages: 35 - 45
Correction to: Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status Johanna JostKlaus Völkerfor the MMH Trial Investigators Correction Open access 24 April 2024 Pages: 47 - 47
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers Christoph StraubeStephanie E. CombsDavid Kaul Research Open access 23 March 2024 Pages: 49 - 56
Effects of cognitive-motor intervention for pediatric posterior fossa tumor survivors: results of a pilot study Vladimir N. KasatkinElizaveta N. RomanovaAlexander F. Karelin Research 15 March 2024 Pages: 57 - 67
Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse Elissa TongPatrick HorsleyMichael Back Research 29 March 2024 Pages: 69 - 76
The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database Ping ZhuPavel S. Pichardo-RojasYoshua Esquenazi Research 16 March 2024 Pages: 77 - 89
Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy Natsuko KondoTadatoshi KinouchiMinoru Suzuki Research 10 April 2024 Pages: 91 - 97
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches Elad MashiachJuan Diego AlzateDouglas Kondziolka Research 17 April 2024 Pages: 99 - 109
Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment Mantas DmukauskasGino CioffiJill S. Barnholtz-Sloan Research Open access 02 April 2024 Pages: 111 - 123
Repurposing mebendazole against triple-negative breast cancer CNS metastasis Adrian J. RodriguesSophia B. ChernikovaMelanie Hayden-Gephart Research Open access 02 April 2024 Pages: 125 - 138
PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor Shizun WangDan ZhangYuqin Liu Research 25 April 2024 Pages: 139 - 149
Perioperative psychological distress in patients with intracranial tumors; a single center study Michael-Karl FehrenbachFlorian WilhelmyJohannes Kasper Research 02 April 2024 Pages: 151 - 157
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition Wietse GeensNathalie VanlaerJohnny Duerinck Case Study 19 March 2024 Pages: 159 - 169
Gamma knife radiosurgery for clival metastasis: case series and systematic review Sakibul HuqRegan M. ShanahanL. Dade Lunsford Case Study 10 April 2024 Pages: 171 - 183
Elevating the findings by substituting in “ISarcoPRM” Ahmad Jasem AbdulsalamMurat KaraLevent Özçakar Correspondence 02 April 2024 Pages: 185 - 186